Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Release Earnings on Monday

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) is expected to release its resultson Monday, July 27th. Analysts expect Shionogi & Co., Ltd. Unsponsored ADR to announce earnings of $0.18 per share and revenue of $970.6930 million for the quarter.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%.The business had revenue of $881.71 million during the quarter, compared to the consensus estimate of $895.52 million. On average, analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 0.6%

Shares of OTCMKTS:SGIOY opened at $8.68 on Friday. The firm has a market capitalization of $14.77 billion, a PE ratio of 10.85, a price-to-earnings-growth ratio of 3.35 and a beta of 0.09. The business has a 50 day simple moving average of $8.86 and a two-hundred day simple moving average of $9.88. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.65 and a 1 year high of $12.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.58 and a quick ratio of 1.46.

Analysts Set New Price Targets

SGIOY has been the topic of several recent analyst reports. The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Monday, June 15th. Jefferies Financial Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Finally, Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.